CT
AMED

ClearAlpha Technologies’s Amedisys AMED Stock Holding History

ClearAlpha Technologies’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-63,816
Closed -$5.91M – 43
2025
Q1 		$5.91M Buy
63,816
+4,163
+7% +$384K 3.74% 8
2024
Q4 		$5.42M Sell
59,653
-18,208
-23% -$1.67M 3.71% 9
2024
Q3 		$7.51M Buy
77,861
+12,612
+19% +$1.23M 2.09% 11
2024
Q2 		$5.99M Buy
65,249
+12,522
+24% +$1.16M 1.98% 12
2024
Q1 		$4.86M Buy
52,727
+5,515
+12% +$517K 2.05% 9
2023
Q4 		$4.49M Buy
+47,212
New +$4.41M 1.69% 6

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

ClearAlpha Technologies's AMED Position: Q2 2025 in Review

ClearAlpha Technologies sold out of Amedisys (AMED) in Q2 2025, closing a stake of 63,816 shares — an estimated $5.91M sold.

ClearAlpha Technologies first reported a position in AMED in Q4 2023 and held it in 6 quarters. The position peaked at $7.51M in Q3 2024. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • ClearAlpha Technologies reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • ClearAlpha Technologies sold 63,816 Amedisys shares in Q2 2025, an estimated $5.91M.
  • ClearAlpha Technologies first reported a position in Amedisys in Q4 2023 and held it in 6 quarters.
  • ClearAlpha Technologies's Amedisys position peaked at $7.51M in Q3 2024.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on ClearAlpha Technologies's 13F filing for Q2 2025, filed 14 Aug 2025.